First Trust Nasdaq Pharmaceuticals ETF
FTXH
FTXH
18 hedge funds and large institutions have $6.18M invested in First Trust Nasdaq Pharmaceuticals ETF in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$322K | |
| 2 | +$104K | |
| 3 | +$84.4K | |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
+$56.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$27.6K |
Top Sellers
| 1 | -$433K | |
| 2 | -$219K | |
| 3 | -$52.5K | |
| 4 |
VCM
Vivaldi Capital Management
Chicago,
Illinois
|
-$43.4K |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
-$26.2K |